Cargando…

Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial Participants

Methylthioninium chloride (MTC) is a standard treatment for methaemoglobinaemia. A preparation of reduced MTC has been reported to increase blood oxygen saturation (SpO(2)) and lower respiratory rates in patients with severe COVID-19. We have developed a stable form of reduced methylthionine (hydrom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arastoo, Mohammad, Mazanetz, Michael P., Miller, Sonya, Shiells, Helen, Hull, Claire, Robinson, Keith, Storey, John M. D., Harrington, Charles R., Wischik, Claude M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531415/ https://www.ncbi.nlm.nih.gov/pubmed/37762050 http://dx.doi.org/10.3390/ijms241813747

Ejemplares similares

Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier
por: Bentham, Peter, et al.
Publicado: (2021)

Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer’s Disease
por: Schelter, Bjoern O., et al.
Publicado: (2019)

Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice
por: Kondak, Constantin, et al.
Publicado: (2023)

Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia
por: Shiells, Helen, et al.
Publicado: (2020)

Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks
por: Schwab, Karima, et al.
Publicado: (2021)

Oral Tau Aggregation Inhibitor for Alzheimer’s Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate
por: Wischik, Claude M., et al.
Publicado: (2022)

Participation in physical activity is associated with reduced nocturnal hypoxaemia in males
por: Stevens, David, et al.
Publicado: (2021)

Modeling Prion-Like Processing of Tau Protein in Alzheimer’s Disease for Pharmaceutical Development
por: Wischik, Claude M., et al.
Publicado: (2018)

Hypoxaemia in a pregnant lady
por: Yamin, Hasan S., et al.
Publicado: (2016)

Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer’s Disease
por: Arastoo, Mohammad, et al.
Publicado: (2020)

Conservative management of COVID-19 associated hypoxaemia
por: Supady, Alexander, et al.
Publicado: (2021)

Hyperoxaemia and hypoxaemia are associated with harm in patients with ARDS
por: Boyle, Andrew J., et al.
Publicado: (2021)

Maternal sildenafil impairs the cardiovascular adaptations to chronic hypoxaemia in fetal sheep
por: Inocencio, Ishmael M., et al.
Publicado: (2020)

Conservative management of COVID-19 associated hypoxaemia
por: Windisch, Wolfram, et al.
Publicado: (2021)

Conservative management of COVID-19 associated hypoxaemia
por: Voshaar, Thomas, et al.
Publicado: (2021)

Conservative management of COVID-19 associated hypoxaemia
por: Voshaar, Thomas, et al.
Publicado: (2021)

Conservative management of COVID-19 associated hypoxaemia
por: Voshaar, Thomas, et al.
Publicado: (2021)

The unfriendly side of “happy hypoxaemia”: Sudden cardiac death
por: Serbanescu-Kele Apor de Zalán, C.M.C., et al.
Publicado: (2022)

Hypoxaemia, sport and polycythaemia: a case from Imperial College London
por: Yasuda, Wakana, et al.
Publicado: (2015)

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer’s Disease: Systematic Review and Meta-Analysis
por: Zabala-Findlay, Alex, et al.
Publicado: (2023)

Bicarbonate: Lack of efficacy in hypoxaemia and acidosis: case report
Publicado: (2020)

Dilemma of countering happy hypoxaemia COVID-19 patients
por: Kobayashi, Keigo, et al.
Publicado: (2021)

Intravascular lymphoma presenting with hypoxaemia, platypnoea and lactic acidosis
por: Englert, Pierre, et al.
Publicado: (2021)

Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
por: Perner, Anders, et al.
Publicado: (2023)

Mechanisms of hypoxaemia in severe pulmonary hypertension associated with COPD
por: Piccari, Lucilla, et al.
Publicado: (2023)

Explainable machine-learning predictions for the prevention of hypoxaemia during surgery
por: Lundberg, Scott M., et al.
Publicado: (2018)

Modelling the effect of ambient oxygen fraction on hypoxaemia during apnoea
por: Hardman, JG
Publicado: (1999)

Nocturnal hypoxaemia in patients with Eisenmenger syndrome: a cohort study
por: Ramakrishnan, Sivasubramanian, et al.
Publicado: (2013)

Hypoxaemia in COVID-19: many pieces to a complex puzzle
por: Busana, Mattia, et al.
Publicado: (2022)

Acute hypoxaemia due to intraoperative lung collapse after repositioning the patient
por: Butala, Bina P, et al.
Publicado: (2011)

Headache in patients with chronic obstructive pulmonary disease: effects of chronic hypoxaemia
por: Özge, A., et al.
Publicado: (2006)

Lung isolation, one-lung ventilation and hypoxaemia during lung isolation
por: Purohit, Atul, et al.
Publicado: (2015)

Hypoxaemia during pregnancy: pulmonary arteriovenous dilatation as a likely cause
por: Veil-Picard, Matthieu, et al.
Publicado: (2014)

Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?
por: Harutyunyan, Gurgen, et al.
Publicado: (2022)

Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT
por: Lang, Min, et al.
Publicado: (2020)

Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
por: Lai, Robert Y. K., et al.
Publicado: (2016)

Erratum: Lai, R.Y.K.; Harrington, C.R.; Wischik, C.M. Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease. Biomolecules 2016, 6, 19
por: Lai, Robert Y. K., et al.
Publicado: (2016)

Platypnoea-orthodeoxia syndrome, an underdiagnosed cause of hypoxaemia: four cases and the possible underlying mechanisms
por: Nassif, M., et al.
Publicado: (2015)

Butorphanol with oxygen insufflation corrects etorphine-induced hypoxaemia in chemically immobilized white rhinoceros (Ceratotherium simum)
por: Haw, Anna, et al.
Publicado: (2014)

Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial
por: Oliphant, Elizabeth Anne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dkj5an1mqjrrmupdri6m207vs9